RT Journal Article
SR Electronic
T1 A multimodal dataset for precision oncology in head and neck cancer
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.29.24308141
DO 10.1101/2024.05.29.24308141
A1 Dörrich, Marion
A1 Balk, Matthias
A1 Heusinger, Tatjana
A1 Beyer, Sandra
A1 Kanso, Hassan
A1 Matek, Christian
A1 Hartmann, Arndt
A1 Iro, Heinrich
A1 Eckstein, Markus
A1 Gostian, Antoniu-Oreste
A1 Kist, Andreas M.
YR 2024
UL http://medrxiv.org/content/early/2024/05/31/2024.05.29.24308141.abstract
AB Head and neck cancer is a common disease and is associated with a poor prognosis. A promising approach to improving patient outcomes is personalized treatment, which uses information from a variety of modalities. However, only little progress has been made due to the lack of large public datasets. We present a multimodal dataset, HANCOCK, that comprises monocentric, real-world data of 763 head and neck cancer patients. Our dataset contains demographical, pathological, and blood data as well as surgery reports and histologic images. We show its potential clinical impact in a multimodal machine-learning setting by proposing adjuvant treatment for previously unidentified risk patients. We found that especially the multimodal model outperformed single-modality models (area under the curve (AUC): 0.85). We believe that HANCOCK will not only open new insights into head and neck cancer pathology but also serve as a major source for researching multimodal machine-learning methodologies in precision oncology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded in part by the Federal Ministry of Education and Research (BMBF) to AOG and ME (01KD2211B) and to AMK (01KD2211A).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Friedrich-Alexander University Erlangen-Nürnberg gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe dataset is publicly available at https://hancock.research.fau.eu/. https://hancock.research.fau.eu/